Copyright
©2009 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Aug 7, 2009; 15(29): 3636-3642
Published online Aug 7, 2009. doi: 10.3748/wjg.15.3636
Published online Aug 7, 2009. doi: 10.3748/wjg.15.3636
A randomized controlled trial of imipramine in patients with irritable bowel syndrome
Heitham Abdul-Baki, Ihab I El Hajj, Lara ElZahabi, Cecilio Azar, Elie Aoun, Assaad Skoury, Hani Chaar, Ala I Sharara, Department of Internal Medicine, Division of Gastroenterology, American University of Beirut Medical Center, Riad El Solh 110 72020, Beirut, Lebanon
Author contributions: Abdul-Baki H and Sharara AI designed the trial; El Hajj II, ElZahabi L, Azar C, Skoury A, Chaar H and Sharara AI provided patients, data and material; Abdul-Baki H, Aoun E and Sharara AI performed data screening and analysis; All authors contributed to writing the draft of the manuscript; Abdul-Baki H and Sharara AI provided the final approval of the manuscript content.
Correspondence to: Ala I Sharara, MD, FACP, Professor of Medicine, Head, Division of Gastroenterology, American University of Beirut Medical Center, PO Box 11-0236, Riad El Solh 110 72020, Beirut, Lebanon. as08@aub.edu.lb
Telephone: +961-1-350000
Fax: +961-1-366098
Received: February 6, 2009
Revised: June 18, 2009
Accepted: June 25, 2009
Published online: August 7, 2009
Revised: June 18, 2009
Accepted: June 25, 2009
Published online: August 7, 2009
Core Tip